GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage.
Lauren A CallenderJohannes SchrothElizabeth C CarrollConor Garrod-KetchleyLisa E L RomanoEleanor HendyAudrey KellyPaul LavenderArne N AkbarJ Paul ChappleSian M HensonPublished in: Nature communications (2021)
GATA3 is as a lineage-specific transcription factor that drives the differentiation of CD4+ T helper 2 (Th2) cells, but is also involved in a variety of processes such as immune regulation, proliferation and maintenance in other T cell and non-T cell lineages. Here we show a mechanism utilised by CD4+ T cells to increase mitochondrial mass in response to DNA damage through the actions of GATA3 and AMPK. Activated AMPK increases expression of PPARG coactivator 1 alpha (PPARGC1A or PGC1α protein) at the level of transcription and GATA3 at the level of translation, while DNA damage enhances expression of nuclear factor erythroid 2-related factor 2 (NFE2L2 or NRF2). PGC1α, GATA3 and NRF2 complex together with the ATR to promote mitochondrial biogenesis. These findings extend the pleotropic interactions of GATA3 and highlight the potential for GATA3-targeted cell manipulation for intervention in CD4+ T cell viability and function after DNA damage.
Keyphrases
- transcription factor
- dna damage
- oxidative stress
- induced apoptosis
- dna repair
- skeletal muscle
- nuclear factor
- dna binding
- poor prognosis
- endothelial cells
- single cell
- randomized controlled trial
- genome wide identification
- toll like receptor
- binding protein
- stem cells
- dendritic cells
- cancer therapy
- regulatory t cells
- signaling pathway
- cell death
- cell cycle arrest
- cell therapy
- risk assessment
- human health
- bone marrow